Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Obstetrics and Gynecology Reports
Published in: Current Obstetrics and Gynecology Reports 1/2014

01-03-2014 | Management of Gestational Trophoblastic Diseases (A Cheung, Section Editor)

Clinical Epidemiology of Gestational Trophoblastic Disease

Authors: Anna E. Strohl, John R. Lurain

Published in: Current Obstetrics and Gynecology Reports | Issue 1/2014

Login to get access

Abstract

The epidemiology of gestational trophoblastic disease (GTD) is not well defined. The rarity of the disease and challenges in data collection limit interpretation of incidence data. Incidence of GTD appears to be influenced by geographic region, with the highest rates occurring in Southeast Asia and Japan. Risk factors for molar pregnancy include extremes of maternal age, reproductive history, and dietary deficiencies. Risk factors for choriocarcinoma include age, ethnicity, history of complete molar pregnancy, and ABO blood group status. With improvements in socioeconomic conditions and diet as well as diagnosis and management of GTD, the incidence of trophoblastic disease is declining worldwide. Future studies should focus on mechanisms by which risk factors influence development and progression of GTD.
Literature
1.
Lurain J. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203:531–9.PubMedCrossRef
2.
Lurain J. Gestational trophoblastic diseases. In: Mayer I, editor. Textbook of uncommon cancer. John Wiley & Sons, Ltd; 2006. p. 532–42
3.
Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic disease. Gynecol Oncol. 2009;112:654–62.PubMedCrossRef
4.
Bracken MB. Incidence and etiology of hydatidiform mole: an epidemiologic review. BJOG. 1987;94:1123–35.CrossRef
5.
Atrash HK, Hogue CJR, Grimes DA. Epidemiology of hydatidiform mole during early gestation. Am J Obstet Gynecol. 1986;154:906–9.PubMedCrossRef
6.
Takeuchi S. Incidence of gestational trophoblastic disease by regional registration in Japan. Hum Reprod. 1987;2:729–34.PubMed
7.
Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973-1983. Lancet. 1986;2:673–7.PubMedCrossRef
8.
Smith HO. Gestational trophoblastic disease: epidemiology and trends. Clin Obstet Gynecol. 2003;46:541–56.PubMedCrossRef
9.
Martin BH, Kim JM. Changes in gestational trophoblastic tumors over four decades: a Korean experience. J Reprod Med. 1998;43:60–8.PubMed
10.
Berkowitz RS, Cramer DW, Bernstein MR, et al. Risk factors for complete molar pregnancy from a case-control study. Amer J Obstet Gynecol. 1985;152:1016–20.CrossRef
11.
Parazzini F, LaVecchia C, Mangili G, et al. Dietary factors and risk of trophoblastic disease. Amer J Obstet Gynecol. 1988;158:93–9.CrossRef
12.
Lage JM, Mark SD, Roberts DJ, et al. A flow cytometric study of 137 fresh hydrophic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol. 1992;79:403–10.PubMedCrossRef
13.
Parazzini F, Mangili G, LaVecchia C, et al. Risk factors for gestational trophoblastic disease: a separate analysis of complete and partial hydatidiform mole. Obstet Gynecol. 1991;78:1039–45.PubMed
14.
Parazzini F, LaVecchia C, Pampallona S. Parental age and risk of complete and partial hydatidiform mole. BJOG. 1986;93:582–5.CrossRef
15.
Sebire NJ, Foskett M, Fisher RA, et al. Risk of partial and complete molar pregnancy in relation to maternal age. BJOG. 2002;109:99–102.PubMedCrossRef
16.
Sand PK, Lurain JR, Brewer JL. Repeat gestational trophoblastic disease. Obstet Gynecol. 1984;63:140–4.PubMed
17.
Berkowitz RS, Im SS, Bernstein MR, Goldstein DP. Gestational trophoblastic disease: subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med. 1998;43:81–6.PubMed
18.
Sebire NJ, Fisher RA, Foskett M, et al. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform mole. BJOG. 2003;110:22–6.PubMedCrossRef
19.
Acaia B, Parazzini F, LaVecchia C, et al. Increased frequency of complete hydatidiform mole in women with repeated abortion. Gynecol Oncol. 1988;31:310–4.PubMedCrossRef
20.
Wang CM, Dixon PH, Decordova S, Hodges MD, Sebire NJ, Ozalp S, et al. Indentification of 13 novel NLRP7 mutations in 2 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region. J Med Genet. 2009;46:569–75.PubMedCrossRef
21.
Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med. 1994;39:155–62.PubMed
22.
Palmer JR, Driscoll SG, Rosenberg L, et al. Oral contraceptive use and risk of gestational trophoblastic tumors. J Natl Cancer Inst. 1999;91:635–40.PubMedCrossRef
23.
Berkowitz RS, Bernstein MR, Harlow BL, et al. Case-control study of risk factors for partial molar pregnancy. Gynecol Oncol. 1995;173:788–94.
24.
Smith HO, Qualls CR, Prarie BA, et al. Trends in gestational choriocarcinoma: a 27-year perspective. Obstet Gynecol. 2003;102:978–87.PubMedCrossRef
25.
Brinton LA, Bracken MB, Connelly RR. Choriocarcinoma incidence in the United States. Am J Epidemiol. 1986;123:1094–100.PubMed
26.
Baltazar JC. Epidemiological features of choriocarcinoma. WHO Bulletin. 1976;54:523–32.
27.
Buckley JD, Henderson BE, Morrow CP, et al. Case-control study of gestational choriocarcinoma. Cancer Res. 1988;48:1004–10.PubMed
28.
Costa HL, Doyle P. Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia - a systematic review. Gynecol Oncol. 2006;100:579–85.PubMedCrossRef
Metadata
Title
Clinical Epidemiology of Gestational Trophoblastic Disease
Authors
Anna E. Strohl
John R. Lurain
Publication date
01-03-2014
Publisher
Springer US
Published in
Current Obstetrics and Gynecology Reports / Issue 1/2014
Electronic ISSN: 2161-3303
DOI
https://doi.org/10.1007/s13669-013-0070-7

Other articles of this Issue 1/2014

Current Obstetrics and Gynecology Reports 1/2014 Go to the issue

Molecular Pathogenesis of Gynecologic Cancer (H Katabuchi and H Tashiro, Section Editors)

Molecular Pathogenesis of Uterine Serous Carcinoma

Management of Gestational Trophoblastic Diseases (A Cheung, Section Editor)

The hCG Group: the Key Molecules in Human Evolution, Human Life, and Human Death

Management of Gestational Trophoblastic Diseases (A Cheung, Section Editor)

Classification and Morphology of Gestational Trophoblastic Disease

Molecular Pathogenesis of Gynecologic Cancer (H Katabuchi and H Tashiro, Section Editors)

Pathogenesis of the Endometriosis-Related Ovarian Neoplasms

Molecular Pathogenesis of Gynecologic Cancer (H Katabuchi and H Tashiro, Section Editors)

The Relationship Between Estrogen and Genes in the Molecular Pathogenesis of Endometrial Carcinoma

Management of Gestational Trophoblastic Diseases (A Cheung, Section Editor)

Management Options of Gestational Trophoblastic Disease